Nurix Therapeutics
NRIX
$16.59
Share price
7.73%
Change (1 day)
65.73%
Change (1 year)
Categories
P/S ratio for Nurix Therapeutics (NRIX)
P/S ratio as of May 2024 (TTM): 11.6
According to Nurix Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.6266. At the end of 2023 the company had a P/S ratio of 4.35.
P/S ratio history for Nurix Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.35 | -71.72% |
| 2022 | 15.4 | -64.39% |
| 2021 | 43.2 | -53.49% |
| 2020 | 92.9 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |